Article
<i>SEC31A-ALK</i> Fusion Gene in Lung Adenocarcinoma
17 Feb 2015
Abstract excerpt
Anaplastic lymphoma kinase (ALK) fusion is a common mechanism underlying pathogenesis of non-small cell lung carcinoma (NSCLC) where these rearrangements represent important diagnostic and therapeutic targets. In this study, we found a new ALK fusion gene, SEC31A-ALK, in lung carcinoma from a 53-year-old Korean man. The conjoined region in the fusion transcript was generated by the fusion of SEC31A exon 21 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
